Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Quaker Chemical (KWR)

Quaker Houghton Q4 sales fell 5% to $444.1 million; Q4 EPS $0.81 vs $1.12 a year earlier

Mixed Impact 3 of 5 earnings Written later

Quaker Houghton reported fourth quarter and full year 2024 results on February 24, 2025. Q4 net sales fell 5% to $444.1 million and diluted EPS fell to $0.81 from $1.12, while full year net income rose to $116.6 million and diluted EPS rose to $6.51 from $6.26, even though full year net sales declined to $1.84 billion from $1.95 billion.

Key points

  • Q4 2024 net sales were $444.1 million, down from $467.1 million in Q4 2023; Q4 net income was $14.2 million, or $0.81 per diluted share, versus $20.2 million, or $1.12, a year earlier
  • Q4 adjusted EBITDA was $64.8 million, down about 16% from $77.0 million, driven by lower sales and operating margins
  • Full year 2024 net income was $116.6 million, or $6.51 per diluted share, compared with $112.7 million, or $6.26, in 2023; full year net sales were $1.84 billion versus $1.95 billion
  • The company expects run-rate cost savings of at least $20 million in 2025 and said it expects revenue, adjusted EBITDA and earnings growth in 2025, but did not provide formal GAAP guidance

The filing

CompanyQuaker Chemical (KWR)
Form8-K, current report
Filed with the SECFeb 24, 2025, 4:37 PM ET
Accession number0000081362-25-000012

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.